Following a landmark ruling in Oklahoma that ordered pharmaceutical giant Johnson & Johnson and its subsidiaries to pay US$572 million for its role in fuelling the state’s opioid crisis, lawyers say the decision could have a profound effect on similar lawsuits in Canada.